Key result
Combined enlarged LA and reduced EF linked to a ~78% rate of cardioembolic stroke.
Why the study?
LA dilatation and heart failure are independent risk factors for ischemic stroke, but their association with cardioembolic stroke needed evaluation.
Are left atrial dilatation and reduced left ventricular ejection fraction associated with cardioembolic stroke in patients with ischemic stroke?
Cohort (n=453)
No
Are left atrial dilatation and reduced left ventricular ejection fraction associated with cardioembolic stroke in patients with ischemic stroke?
Left atrial dilatation and reduced ejection fraction are strongly associated with cardioembolic stroke, suggesting a potential role for anticoagulation in secondary prevention for these patients.
Answers are grounded in this paper and cite their sources.
May support risk stratification in ischemic stroke but should not yet guide anticoagulation; leaves open need for randomized trials.
Objective: Left atrial (LA) dilatation and heart failure are independent risk factors for ischemic stroke. The goal of this study is to evaluate the association between LA dilatation and reduced left ventricular ejection fraction (EF) with cardioembolic stroke. Methods: Four hundred fifty-three patients with ischemic stroke admitted to the University of California, Irvine between 2016 and 2017 were included based on the following criteria: age >18 and availability of echocardiogram. Stroke was categorized into cardioembolic and non-cardioembolic. EF was categorized into normal: 52–72% (male), 54–74% (female), mildly abnormal: 41–51% (male), 41–53% (female), moderately abnormal: 30–40%, and severely abnormal: <30%. LA volume was categorized into normal (≤34 ml/m 2 ) vs. enlarged (≥35 ml/m 2 ). Other variables included gender, hypertension [systolic blood pressure (SBP) ≥ 140 or diastolic blood pressure (DBP) ≥ 90], and known history of atrial fibrillation (Afib). Results: Two hundred eighteen patients had cardioembolic, and 235 had non-cardioembolic stroke. Among patients with cardioembolic stroke, 49 (22.4%) and 142 (65%) had reduced EF and enlarged LA, respectively, as compared with 19 (8.1%) and 65 (27.7%) patients with non-cardioembolic stroke ( p < 0.0001). The odds of cardioembolic stroke were 2.0 (95% CI: 0.1–6.0) and 8.8 times (95% CI: 1.9–42.3) higher in patients with moderately and severely reduced EF, respectively, than in patients with normal EF. The odds of cardioembolic stroke was 2.4 times (95% CI: 1.5–3.9) higher in patients with enlarged LA than in patients with normal LA size. Compared with patients with normal LA and EF, patients with combined enlarged LA and reduced EF had significantly higher rates of Afib (43.4 vs. 9.0%, p < 0.0001) and cardioembolic stroke (78.3 vs. 43.4%, p < 0.0001). Conclusions: LA dilatation along with reduced EF is a reliable predictor of Afib and cardioembolic stroke. Further studies are warranted to determine the benefit of anticoagulation for secondary stroke prevention in such patient population.
No takes yet. Share an insight, caveat, or question.
Farahabadi et al. (2021) conducted a cohort in Ischemic stroke (n=453). Combined enlarged left atrium and reduced ejection fraction vs. Normal left atrium and normal ejection fraction was evaluated on Cardioembolic stroke (p=<0.0001). Combined enlarged left atrium and reduced ejection fraction increased the rate of cardioembolic stroke compared to patients with normal parameters.
Synapse has enriched 10 related papers. Consider them for comparative context: